InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by McKenzie Kathryn B, Chief Financial Officer. Insider active across 1 companies, notably Neogenomics INC. Cumulatively, 6 disclosures have been recorded. Total volume traded: €115k. The latest transaction was filed on 11 January 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
€16,8112,100 shares@ €8.0050.0016% mcap22.7% of flow
Common Stock
SEC:0001077183-22-000002·
€16,8112,100 shares@ €8.0050.0016% mcap11.3% of flow
Common Stock
SEC:0001077183-22-000002:0·
030,572 shares0
Common Stock
SEC:0001077183-21-000276·
030,572 shares0
Common Stock
SEC:0001077183-21-000276:0·
€57,2911,846 shares@ €31.03520.0053% mcap77.3% of flow
Common Stock
SEC:0001077183-21-000260·
€57,2911,846 shares@ €31.03520.0053% mcap38.7% of flow
Common Stock
SEC:0001077183-21-000260:0·
6 of 6 declarations
About McKenzie Kathryn B
Kathryn B. McKenzie is the Chief Financial Officer and Chief Sustainability/Risk Officer at NEOGENOMICS INC. She is responsible for the company's financial management, including financial planning and performance analysis. McKenzie plays a key role in optimizing financial resources and NEOGENOMICS' growth strategy. Her expertise in finance and sustainability is essential for the company.
